“Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration”. Medinformatics, vol. 1, no. 1, Oct. 2023, pp. 35-42, https://doi.org/10.47852/bonviewMEDIN32021466.